Insider Buy/Sell Details for the Healthcare Sector — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (372)
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
102,969
Price
$21.14
Total Value
$2.18M
Shares Held After
4,476,487
% of Holdings
2.2%
Omada Health, Inc. (OMDA)
Cook Steven L. — Chief Financial Officer
Shares
17,950
Price
$21.07
Total Value
$378.17K
Shares Held After
115,409
% of Holdings
13.5%
Omada Health, Inc. (OMDA)
Gracey Craig — Chief Accounting Officer
Shares
2,083
Price
$21.00
Total Value
$43.74K
Shares Held After
858
% of Holdings
70.8%
GALECTIN THERAPEUTICS INC (GALT)
Jamil Khurram — Chief Medical Officer
Shares
47,467
Price
$5.04
Total Value
$239.23K
Shares Held After
0
% of Holdings
100.0%
GALECTIN THERAPEUTICS INC (GALT)
Shlevin Harold H. — Director
Shares
22,268
Price
$5.04
Total Value
$112.23K
Shares Held After
6,500
% of Holdings
77.4%
Septerna, Inc. (SEPN)
Shaikhly Samira — Chief People Officer
Shares
2,178
Price
$35.18
Total Value
$76.62K
Shares Held After
793
% of Holdings
73.3%
Teladoc Health, Inc. (TDOC)
Bliss Kelly — President, U.S. Group Health
Shares
2,500
Price
$8.50
Total Value
$21.25K
Shares Held After
89,878
% of Holdings
2.7%
Disc Medicine, Inc. (IRON)
Khara Rahul — Chief Legal Officer
Shares
1,649
Price
$75.00
Total Value
$123.67K
Shares Held After
52,173
% of Holdings
3.1%
CareDx, Inc. (CDNA)
Hanna John Walter JR — Director
Shares
39,900
Price
$29.24
Total Value
$1.17M
Shares Held After
661,959
% of Holdings
5.7%
Guardant Health, Inc. (GH)
Talasaz AmirAli — Director
Shares
40
Price
$153.00
Total Value
$6.12K
Shares Held After
1,881,336
% of Holdings
0.0%
Guardant Health, Inc. (GH)
Talasaz AmirAli — Director
Shares
46,663
Price
$152.20
Total Value
$7.10M
Shares Held After
1,881,376
% of Holdings
2.4%
Guardant Health, Inc. (GH)
Talasaz AmirAli — Director
Shares
70,513
Price
$151.47
Total Value
$10.68M
Shares Held After
1,928,039
% of Holdings
3.5%
Guardant Health, Inc. (GH)
Talasaz AmirAli — Director
Shares
25,812
Price
$150.53
Total Value
$3.89M
Shares Held After
1,998,552
% of Holdings
1.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
3,024
Price
$107.76
Total Value
$325.87K
Shares Held After
466,077
% of Holdings
0.6%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
2,318
Price
$106.63
Total Value
$247.17K
Shares Held After
469,101
% of Holdings
0.5%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
848
Price
$105.78
Total Value
$89.70K
Shares Held After
471,419
% of Holdings
0.2%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
19,093
Price
$107.76
Total Value
$2.06M
Shares Held After
2,412,747
% of Holdings
0.8%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
14,613
Price
$106.63
Total Value
$1.56M
Shares Held After
2,431,840
% of Holdings
0.6%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
5,471
Price
$105.78
Total Value
$578.72K
Shares Held After
2,446,453
% of Holdings
0.2%
HALOZYME THERAPEUTICS, INC. (HALO)
Krishnan Mahesh — Director
Shares
7,304
Price
$75.00
Total Value
$547.80K
Shares Held After
14,462
% of Holdings
33.6%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
157
Price
$111.20
Total Value
$17.46K
Shares Held After
461,794
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,199
Price
$110.67
Total Value
$132.69K
Shares Held After
461,951
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,239
Price
$109.75
Total Value
$135.98K
Shares Held After
463,150
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,688
Price
$108.28
Total Value
$182.78K
Shares Held After
464,389
% of Holdings
0.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
907
Price
$111.20
Total Value
$100.86K
Shares Held After
2,385,747
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
7,602
Price
$110.67
Total Value
$841.31K
Shares Held After
2,386,654
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
7,833
Price
$109.75
Total Value
$859.67K
Shares Held After
2,394,256
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
10,658
Price
$108.28
Total Value
$1.15M
Shares Held After
2,402,089
% of Holdings
0.4%
Beta Bionics, Inc. (BBNX)
Feider Stephen — Chief Financial Officer
Shares
4,896
Price
$17.03
Total Value
$83.38K
Shares Held After
165,931
% of Holdings
2.9%
NEUROCRINE BIOSCIENCES INC (NBIX)
Lippoldt Darin — Chief Legal Officer
Shares
1,690
Price
$170.81
Total Value
$288.68K
Shares Held After
54,729
% of Holdings
3.0%
NEUROCRINE BIOSCIENCES INC (NBIX)
Lippoldt Darin — Chief Legal Officer
Shares
8,110
Price
$170.03
Total Value
$1.38M
Shares Held After
54,729
% of Holdings
12.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
430
Price
$548.96
Total Value
$236.05K
Shares Held After
40,513
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,702
Price
$548.29
Total Value
$933.19K
Shares Held After
40,943
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
759
Price
$547.12
Total Value
$415.26K
Shares Held After
42,645
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,705
Price
$546.28
Total Value
$931.40K
Shares Held After
43,404
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,165
Price
$545.30
Total Value
$1.18M
Shares Held After
45,109
% of Holdings
4.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,594
Price
$544.40
Total Value
$867.78K
Shares Held After
47,274
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
585
Price
$543.37
Total Value
$317.87K
Shares Held After
48,868
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$541.86
Total Value
$43.35K
Shares Held After
49,453
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$541.24
Total Value
$194.85K
Shares Held After
49,533
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$539.98
Total Value
$64.80K
Shares Held After
49,893
% of Holdings
0.2%
ANI PHARMACEUTICALS INC (ANIP)
CAREY STEPHEN P. — SVP & CFO
Shares
2,850
Price
$84.12
Total Value
$239.74K
Shares Held After
177,543
% of Holdings
1.6%
Monte Rosa Therapeutics, Inc. (GLUE)
Manning Anthony M. — Director
Shares
10,000
Price
$23.11
Total Value
$231.10K
Shares Held After
0
% of Holdings
100.0%
Privia Health Group, Inc. (PRVA)
Morris Matthew Shawn — Director
Shares
63,212
Price
$25.33
Total Value
$1.60M
Shares Held After
76,651
% of Holdings
45.2%
Monte Rosa Therapeutics, Inc. (GLUE)
Janku Filip — Chief Medical Officer
Shares
6,000
Price
$22.95
Total Value
$137.70K
Shares Held After
59,992
% of Holdings
9.1%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
55
Price
$84.59
Total Value
$4.65K
Shares Held After
0
% of Holdings
100.0%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
286
Price
$84.59
Total Value
$24.19K
Shares Held After
0
% of Holdings
100.0%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
9
Price
$84.59
Total Value
$761.31
Shares Held After
0
% of Holdings
100.0%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
349
Price
$84.59
Total Value
$29.52K
Shares Held After
0
% of Holdings
100.0%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
44,363
Price
$84.02
Total Value
$3.73M
Shares Held After
55
% of Holdings
99.9%
Showing 301–350 of 372 transactions (page 7 of 8)